Lawyers and Settlements
Home Page >> Alere INRatio and INRatio 2 Recall >> Articles

Alere INRatio Recall Articles

Alere Inc. In Tough over Recalled INRatio, Abbott Merger in Jeopardy

Alere Inc. In Tough over Recalled INRatio, Abbott Merger in Jeopardy January 3, 2017. By Gordon Gibb.
Georgetown, DE: An Alere lawsuit filed by former suitor Abbott Laboratories Inc. (Abbott) over a proposed merger is, for the moment, redirecting attention away from the failed INRatio measuring device that was recalled in July. The recalled product nonetheless has a role in the recent performance of Alere Inc. (Alere) that has prompted Abbott to back away. This, in spite of recent assurances from the US Food and Drug Administration (FDA) that any failings of the Alere INRatio device had no bearing on the relationship between warfarin (Coumadin) and Xarelto (rivaroxaban), and the subsequent approval of the latter.
Read [ Alere Inc. In Tough over Recalled INRatio, Abbott Merger in Jeopardy ]

Three Points for Alere INRatio Device

Three Points for Alere INRatio Device December 21, 2016. By Jane Mundy.
Dallas, TX: Negligence allegations against Janssen Pharmaceuticals, Johnson & Johnson and Bayer AG may have fizzled somewhat. Two recent issues do not bode well for plaintiffs filing Alere INRatio lawsuits. The FDA recently announced that the Alere INRatio anti-coagulation monitoring device had no substantial effect on the outcome of the ROCKET-AF trial and in turn did not significantly favor Xarelto as earlier suspected, and a California Alere class action suit in September was dismissed.
Read [ Three Points for Alere INRatio Device ]

FDA Weighs in Alere Recall and Potential for Skewed Results

FDA Weighs in Alere Recall and Potential for Skewed Results December 3, 2016. By Gordon Gibb.
Washington, DC: On the heels of a published report in BMJ with regard to the Alere INRatio device, the Alere Recall
Read [ FDA Weighs in Alere Recall and Potential for Skewed Results ]

Janssen Knew About Issues With Alere INRatio Device

Janssen Knew About Issues With Alere INRatio Device October 6, 2016. By Heidi Turner.
Boston, MA: A new report from BMJ suggests Janssen Pharmaceuticals knew about problems with the Alere INRatio device used during a trial to test a drug's safety but did not inform regulators about those issues. The report, published online September 28, 2016, involves an investigation conducted by The BMJ into whether Janssen and Bayer, co-makers of rivaroxaban, knew about problems with the INRatio device.
Read [ Janssen Knew About Issues With Alere INRatio Device ]

Alere Inaccuracies may lead to Legal Action

Alere Inaccuracies may lead to Legal Action September 24, 2016. By Jane Mundy.
Dallas, TX: Now that the blood-testing device called Alere INRatio is known to cause misreadings, attorneys are beginning to focus on blood thinner-related injuries. And there may be legal action against Alere, the manufacturer.
Read [ Alere Inaccuracies may lead to Legal Action ]

Request Alere INRatio Recall Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Defendant:
Describe your complaint:

By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Subscribe to our free weekly newsletter.

Check Claim Status Advertise with us Legal Funding


Legal Services:

Facebook



 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice


This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2017 Online Legal Media. All rights reserved.


Visit other Online Legal Media Websites:

BigClassAction.comCALaborLawNews.com
OnlineLegalMarketing.comHealthEffectsOfAsbestos.com
Get Legal Help